PARSIPPANY, N.J.-- (BUSINESS WIRE)--Pyros Pharmaceuticals, Inc. (Pyros or the Company), a leader in the development of enhanced specialty pharmaceuticals for rare diseases, announced today that the ...

Credit: Pyros Pharmaceuticals. Vigafyde is supplied as a peppermint-flavored oral solution in a 150mL bottle. Vigafyde ™, a ready-to-use oral solution formulation of vigabatrin, is now available for ...

"Parents with children who have infantile spasms are dealing with multiple issues and concerns when caring for their child. The experts at PANTHERx have been helping children and infants with ...

Vigafyde is a concentrated solution and requires a smaller volume than other vigabatrin products to obtain the same dosage. The Food and Drug Administration (FDA) has approved Vigafyde ™, a ...

Upsher-Smith’s rare disease portfolio continues to grow with the addition of high-quality medications that match or exceed the level of service provided by innovator brands. The Company offers three ...

PITTSBURGH, March 24, 2025 /PRNewswire/ -- PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by ...